Catherine Rehder, PhD, FACMG Associate Professor of Pathology, Director of the Division of Molecular Pathology, Genetics & Genomics Duke University
Dr. Rehder directs the cytogenetics and molecular diagnostics laboratories of the Duke University Health System. She currently serves on the COG Cytogenetics Committee and the editorial board of Genetics in Medicine, and co-chairs the ClinGen Lysosomal Diseases Expert Panel. Previously, she has served on the ACMG Laboratory Quality Assurance committee, including a term as committee chair; the ACMG board of directors, including a term as Treasurer; and the CAP/ACMG Cytogenetics Committee, including a term as Vice-Chair. In addition to her roles as laboratory director, lecturer, and active participant on several intramural and extramural committees, Dr. Rehder is an author on >80 peer-reviewed publications, review articles, and laboratory guidelines on a wide variety of cytogenetics and molecular genetics topics. Her primary areas of interest and publication include the reporting practices of genomic testing, Pompe disease and other glycogen storage diseases, as well as newborn screening and sequence variant interpretation.